1. Duloxetine, a generic version of Eli Lilly’s drug Cymbalta, is used to treat major depressive disorder, general anxiety disorder and fibromyalgia.
2. Gocovri treats dyskinesia, a side effect of a medication prescribed to most Parkinson’s disease patients.
3. Kymriah uses patients’ genetically modified immune cells to fight relapsed acute lymphoblastic leukemia.
4. Vabomere is an intravenous antibacterial drug intended for adults with complicated urinary tract infections.
5. Benznidazole is the first FDA-approved treatment for Chagas disease in the U.S.
6. HeartMate 3 Left Ventricular Assist System pumps blood via a magnetically levitated propeller that simulates the beating of a heart.
7. Victoza may now be used to reduce the risk of cardiovascular events — like heart attacks and strokes — in type 2 diabetes patients.
More articles on supply chain:
Novartis, CMS collaborate on outcomes-based pricing for $465k leukemia drug
FDA approves Novartis’ ‘breakthrough’ leukemia drug — with a price tag of $475k
Abbott issues software update to prevent pacemaker hacks: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
